Last update 24 Mar 2025

Asengeprast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
FT 011, FT-001, FT-011
+ [3]
Target
Action
antagonists
Mechanism
GPR68 antagonists(G protein-coupled receptor 68 antagonists)
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC20H17NO5
InChIKeyUIWZIDIJCUEOMT-PKNBQFBNSA-N
CAS Registry1001288-58-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Scleroderma, DiffusePhase 2
Australia
19 Jul 2021
Scleroderma, DiffusePhase 2
Netherlands
19 Jul 2021
Scleroderma, DiffusePhase 2
Poland
19 Jul 2021
Scleroderma, DiffusePhase 2
Spain
19 Jul 2021
Scleroderma, DiffusePhase 2
Ukraine
19 Jul 2021
SclerodermaPhase 2
Australia
-
GlaucomaPhase 1
Australia
13 May 2019
Diabetic NephropathiesPhase 1
Australia
20 May 2013
Scleroderma, SystemicPreclinical
United States
10 Oct 2023
Chronic Kidney DiseasesPreclinical-03 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
30
(FT011 200mg)
tqjtevprpb(rbsmqcvhuo) = psuytoetkj viomjprqjo (jekipumyzt, 1.94)
-
20 Dec 2023
(FT011 400mg)
tqjtevprpb(rbsmqcvhuo) = dxcwcmopyz viomjprqjo (jekipumyzt, 4.27)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free